Literature DB >> 166035

Studies on the immune response and pathogenesis of Sendai virus infection of mice. III. The effects of cyclophosphamide.

G Blandford.   

Abstract

Studies of the effects of cyclophosphamide on a non-lethal primary Sendai virus infection of mice are reported. Treatment with cyclophosphamide resulted in failure to limit or eradicate virus, diminished and delayed the appearance of immunoglobulin-secreting cells in the lungs and the production of local and serum antibody, reduced and delayed the appearance of bronchial basement membrane damage and the desquamation of infected mucosal cells, and reduced the incidence of immune complex deposition in the kidneys. Evidence is presented which indicated that some escape from immunosuppression occured by day 6, resulting in local antibody production. The appearance of the local antibody response was associated with increased tissue damage in the lungs and the deposition of immune complexes of viral antigen and antibody in the kidney. Nine further experiments were performed in mice to investigate this renal manifestation and preliminary results are presented. In four of seven Sendai and one of two avirulent influenza A (Kunz) virus infections glomerular immune complexes were found. Studies in C3H and C57 B1 mice and their F1 hybrid suggested that genetic factors play some part in the renal findings. The results are discussed with respect to the possible beneficial and harmful effects of the immune response to trivial respiratory virus infections.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 166035      PMCID: PMC1445918     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  18 in total

1.  Studies on the immune response and pathogenesis of Sendai virus infection of mice. II. The immunoglobulin class of plasma cells in the bronchial sub-mucosa.

Authors:  G Blandford; R B Heath
Journal:  Immunology       Date:  1974-03       Impact factor: 7.397

2.  Glomerulonephritis associated with immune complex deposits and viral particles in spontaneous murine leukemia. An electron microscopic study with immunofluorescence.

Authors:  R R Pascal; M N Koss; R L Kassel
Journal:  Lab Invest       Date:  1973-08       Impact factor: 5.662

3.  Induction of systemic delayed hypersensitivity during experimental viral infection of the respiratory tract with a myxovirus or paramyxovirus.

Authors:  R E Wetherbee
Journal:  J Immunol       Date:  1973-07       Impact factor: 5.422

4.  Immune complex glomerulonephritis in one-year-old C57BL-6 mice induced by endogenous murine leukemia virus and erythrocyte antigens.

Authors:  D D Porter; H G Porter; N A Cox
Journal:  J Immunol       Date:  1973-12       Impact factor: 5.422

5.  Parainfluenza virus Sendai infection in macrophages, ependyma, choroid plexus, vascular endothelium and respiratory tract of mice.

Authors:  C A Mims; F A Murphy
Journal:  Am J Pathol       Date:  1973-03       Impact factor: 4.307

6.  Studies on the immune response and pathogenesis of Sendai virus infection of mice. I. The fate of viral antigens.

Authors:  G Blandford; R B Heath
Journal:  Immunology       Date:  1972-04       Impact factor: 7.397

7.  Pathogenesis of Sendai virus infection in mice.

Authors:  L H Appell; R M Kovatch; J M Reddecliff; P J Gerone
Journal:  Am J Vet Res       Date:  1971-11       Impact factor: 1.156

8.  Arthus reaction and pneumonia.

Authors:  G Blandford
Journal:  Br Med J       Date:  1970-03-21

Review 9.  Effects of anti-lymphoid sera on viral infections.

Authors:  M S Hirsch; F A Murphy
Journal:  Lancet       Date:  1968-07-06       Impact factor: 79.321

10.  Respiratory diseases in cyclophosphamide-treated mice. II. Decreased virulence of PR8 influenza virus.

Authors:  S H Singer; P Noguchi; R L Kirschstein
Journal:  Infect Immun       Date:  1972-06       Impact factor: 3.441

View more
  12 in total

1.  Pathological alterations of ependyma and choroid plexus after experimental cerebral infection of mice with Sendai virus.

Authors:  G Schwendemann; J Löhler
Journal:  Acta Neuropathol       Date:  1979-04-12       Impact factor: 17.088

2.  Susceptibility of inbred and outbred mouse strains to Sendai virus and prevalence of infection in laboratory rodents.

Authors:  J C Parker; M D Whiteman; C B Richter
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

3.  Modulation of delayed-type hypersensitivity and cellular immunity to microbial vaccines: effects of cyclophosphamide on the immune response to tularemia vaccine.

Authors:  M S Ascher; D Parker; J L Turk
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

4.  Resistance/susceptibility to lethal Sendai virus infection genetically linked to a mucociliary transport polymorphism.

Authors:  D G Brownstein
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

Review 5.  Protease-dependent virus tropism and pathogenicity.

Authors:  Y Nagai
Journal:  Trends Microbiol       Date:  1993-06       Impact factor: 17.079

6.  Respiratory syncytial virus infection in cyclophosphamide-treated cotton rats.

Authors:  R A Johnson; G A Prince; S C Suffin; R L Horswood; R M Chanock
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

7.  Pneumotropism of Sendai virus in relation to protease-mediated activation in mouse lungs.

Authors:  M Tashiro; M Homma
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

8.  Immunoglobulin class-specific antibody response in serum, spleen, lungs, and bronchoalveolar washings after primary and secondary sendai virus infection of germfree mice.

Authors:  D Charlton; G Blandford
Journal:  Infect Immun       Date:  1977-09       Impact factor: 3.441

9.  Cell-mediated immunity induced in mice after vaccination with a protease activation mutant, TR-2, of Sendai virus.

Authors:  M Tashiro; Y Fujii; K Nakamura; M Homma
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

10.  Sendai virus in nude and germ-free rats.

Authors:  P Carthew; S Sparrow
Journal:  Res Vet Sci       Date:  1980-11       Impact factor: 2.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.